Fugazi,
<<I have doubts that the NDA announcement will severely influence the stock. Hope I'm wrong.>>
<<On the Menu for lgnd is the NDA announcement and the LLY drug/cash decision.>>
I have to agree with you. The NDA is widely expected, and I cannot see its announcement generating a lasting gain in the stock price (it has already been discounted, in all likelihood.)
However, the LLY deal for the Seragen compound is another matter. Depending on the specifics of its ultimate resolution, this deal could significantly effect LGND, both near-term and longer-term. My own impression (just my perception, nothing more) is that this deal is currently viewed with some suspicion. A "neat" (read: easy to understand and with consequences that are easily projected) resolution would be a real positive for the stock, in my view. Mind you, what is best for the stock, near-term, may not always be best for the company, longer-term. With luck, these goals will coincide, in this instance.
Regards,
RB |
